GemPharmatech's high P/E ratio is alarming due to its foreca...

GemPharmatech's high P/E ratio is alarming due to its forecast growth being lower than the market. The weak earnings outlook and slower growth indicate a potential share price decline, posing a significant risk to shareholders and potential investors.